CLDI
Price
$1.57
Change
+$0.12 (+8.28%)
Updated
Sep 26 closing price
Capitalization
8.4M
DYN
Price
$13.15
Change
+$0.57 (+4.53%)
Updated
Sep 26 closing price
Capitalization
1.87B
31 days until earnings call
Interact to see
Advertisement

CLDI vs DYN

Header iconCLDI vs DYN Comparison
Open Charts CLDI vs DYNBanner chart's image
Calidi Biotherapeutics
Price$1.57
Change+$0.12 (+8.28%)
Volume$131.5K
Capitalization8.4M
Dyne Therapeutics
Price$13.15
Change+$0.57 (+4.53%)
Volume$1.4M
Capitalization1.87B
CLDI vs DYN Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. DYN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Buy and DYN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CLDI: $1.57 vs. DYN: $13.15)
Brand notoriety: CLDI and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 21% vs. DYN: 52%
Market capitalization -- CLDI: $8.4M vs. DYN: $1.87B
CLDI [@Biotechnology] is valued at $8.4M. DYN’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 5 bullish TA indicator(s).

  • CLDI’s TA Score: 5 bullish, 3 bearish.
  • DYN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DYN is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а +1.95% price change this week, while DYN (@Biotechnology) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.96%. For the same industry, the average monthly price growth was +9.24%, and the average quarterly price growth was +51.43%.

Reported Earning Dates

DYN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.87B) has a higher market cap than CLDI($8.4M). DYN YTD gains are higher at: -44.185 vs. CLDI (-88.623). CLDI has higher annual earnings (EBITDA): -17.92M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. CLDI (5.28M). CLDI has less debt than DYN: CLDI (4.01M) vs DYN (121M). CLDI (0) and DYN (0) have equivalent revenues.
CLDIDYNCLDI / DYN
Capitalization8.4M1.87B0%
EBITDA-17.92M-437.37M4%
Gain YTD-88.623-44.185201%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.28M684M1%
Total Debt4.01M121M3%
TECHNICAL ANALYSIS
Technical Analysis
CLDIDYN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
51%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWVAX12.490.12
+0.97%
Hotchkis & Wiley Sm Cp Divers Val A
FSCAX32.650.31
+0.96%
Nuveen Small Cap Value A
EAAAX17.070.14
+0.83%
Gabelli Entpr Mergers & Acquisitions AAA
OGFAX99.710.60
+0.60%
JPMorgan Equity Index R6
PGPCX27.770.10
+0.36%
George Putnam Balanced C

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with ORYZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then ORYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
+8.28%
ORYZF - CLDI
37%
Loosely correlated
-22.74%
DYN - CLDI
35%
Loosely correlated
+4.53%
DSGN - CLDI
31%
Poorly correlated
+7.53%
RYTM - CLDI
30%
Poorly correlated
+0.02%
RXRX - CLDI
30%
Poorly correlated
+1.94%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+4.53%
CRNX - DYN
58%
Loosely correlated
+27.92%
RNA - DYN
58%
Loosely correlated
+5.17%
IDYA - DYN
52%
Loosely correlated
+4.44%
SYRE - DYN
52%
Loosely correlated
+4.04%
XNCR - DYN
51%
Loosely correlated
+12.00%
More